aspsirna1922 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna1922
siRNA Name: si747/49_3D11
Gene:epidermal growth factor receptor (EGFR)
Disease:Cancer
Wild allele/target (5'->3'): UCAAGGAAUUAAGAGAAGCAACAUCUCC
Mutant allele/target (5'->3'):UCAAGGAA----------CAACAUCUCC
Target Mutation: c.2235_2243delGGAATTAAG, p.Leu747_Glu749del
Wild siRNA (As strand):AGUUCCUUAAUUCUCUUCGUUGUAGAGG
ASP-siRNA (As strand):AGUUCCUU---GUUGUAGAGG
Mismatch position in siRNA: DEL_12,13,14
Mutant allele (5'->3'): UCAAGGAA----------CAACAUCUCC
ASP-siRNA (As strand):AGUUCCUU---GUUGUAGAGG
ASP-siRNA efficacy for mutant allele:60
Wild allele (5'->3'): UCAAGGAAUUAAGAGAAGCAACAUCUCC
ASP-siRNA (As strand):AGUUCCUU---GUUGUAGAGG
ASP-siRNA efficacy for wild allele:5
Percentage discrimination for ASP-siRNA:55
Wild allele (5'->3'): UCAAGGAAUUAAGAGAAGCAACAUCUCC
Wild siRNA (As strand):AGUUCCUUAAUUCUCUUCGUUGUAGAGG
Wild sirna efficacy for wild allele:59
Wild allele (5'->3'): UCAAGGAAUUAAGAGAAGCAACAUCUCC
ASP-siRNA (As strand):AGUUCCUU---GUUGUAGAGG
Wild sirna efficacy for mutant allele:11
Percentage discrimination for wild siRNA:48
Concentration:20nM
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: P00533
Target sequence: UCAAGGAACCAACAUCUCC
Genbank Accesion: NM_005228.3
Cell-line: HeLa
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Applied Biosystems
Post-transfection duration: 24 hours
OMID ID: 211980
KEGG disease ID:H00013
Reference:23951344

.
.
.
.
.
.
.
.
.
.
.

.

.

.